Find a site near you

The COPCOV trial is approaching its final months of recruitment. As of 14 Sept, COPCOV sites have enrolled 2,848 study participants. New sites in Benin, Côte d’Ivoire, Indonesia, Kenya and Nepal joined those in Mali, Pakistan and Zambia, and now closed sites in Thailand, Niger and the UK. We plan to finish recruitment of new participants by the end of Sept, although that may be extended to the end of Oct with local team approval where drug shelf-life allows and further recruitment is possible.